Citius Oncology Presents Quality of Life Results for CTCL at EORTC Meeting
What happened
Results from Study 302, concerning LYMPHIR in adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL), were presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group meeting in Berlin. Christiane Querfeld, affiliated with City of Hope, delivered the oral presentation, which detailed sustained improvement in skin-related quality of life measures. Citius Oncology also announced a partnership with Cutaneous Lymphoma Foundation for a workshop on CTCL care.
From prnewswire.com
Why it matters
The presentation shared clinical results from a pivotal trial (Study 302). The partnership between Citius Oncology and Cutaneous Lymphoma Foundation highlights the importance of quality of life in the treatment of CTCL.
From prnewswire.com
Who's involved
- Cutaneous Lymphoma FoundationPartnered with Citius Oncology for a workshop on quality of life in CTCL care.
- City of HopeAffiliated with Christiane Querfeld, who delivered the oral presentation on the trial results.
- Christiane QuerfeldDelivered the oral presentation on the sustained improvement in quality of life measures.
Keep exploring
The entities involved
-
Cutaneous Lymphoma Foundation
nonprofit organization in Birmingham, United States
Nothing else this week.
-
City of Hope
healthcare organization in Lancaster, United States
- Berlin